Conclusion: The results of this meta-analysis seem to support that periodontal treatment with aPDT + Doxy possesses the best efficacy in lowering HbA1c% of non-smoking CP without severe T2DM ...

Glucose homeostasis regulation is the core of T2DM treatment, this review highlights a new signaling molecule, RNAkine, which has emerged as a critical regulator of glucose homeostasis.

The purpose of this pilot study was to investigate which markers among various systemic disease parameters are affected by periodontal treatment in patients with T2DM. Methods: Twelve patients ...

A study published in the BMJ in 2024 indicated that both MAFLD and T2DM contribute to a state ... significantly impacts both the development and treatment of MAFLD. Dietary practices that ...

Now, the US Food and Drug Administration (FDA) has issued a final guidance for industry on how to use clinical trials to show that a new T2DM treatment is not associated with an unacceptable ...

Antibiotics are powerful and fast-acting drugs that treat bacterial infections. However, overuse and misuse has caused ...

A new systematic review and meta-analysis published in the Clinical Nutrition ESPEN revealed promising outcomes for the ...

People with T2DM with impaired kidney function are at a very high risk of CVD, and as such, it is imperative to implement treatment strategies that safeguard kidney function. 7 Effective ...

Although gut microbiota and lipid metabolites have been suggested to be closely associated with type 2 diabetes mellitus (T2DM), the interactions between gut microbiota, ...

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company was granted a key international patent from the ...

Raymond James analyst Steven Seedhouse raised the firm’s price target on Viking Therapeutics (VKTX) to $125 from $122 and keeps a Strong Buy ...